Lazari Capital Management, Inc. Bristol Myers Squibb CO Transaction History
Lazari Capital Management, Inc.
- $266 Billion
- Q2 2025
A detailed history of Lazari Capital Management, Inc. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Lazari Capital Management, Inc. holds 18,282 shares of BMY stock, worth $851,027. This represents 0.32% of its overall portfolio holdings.
Number of Shares
18,282
Previous 18,449
0.91%
Holding current value
$851,027
Previous $1.13 Billion
24.79%
% of portfolio
0.32%
Previous 0.46%
Shares
9 transactions
Others Institutions Holding BMY
# of Institutions
2,668Shares Held
1.58BCall Options Held
26.1MPut Options Held
23.8M-
Vanguard Group Inc Valley Forge, PA195MShares$9.07 Billion0.15% of portfolio
-
Black Rock Inc. New York, NY159MShares$7.39 Billion0.15% of portfolio
-
Jpmorgan Chase & CO New York, NY108MShares$5.03 Billion0.52% of portfolio
-
State Street Corp Boston, MA94.8MShares$4.41 Billion0.24% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA70.8MShares$3.3 Billion0.59% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $99B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...